CV Lattes
ORCID
Google Scholar Citations
Universidade Federal de Minas Gerais (UFMG). Instituto de Ciências Biológicas (Institutional affiliation from the last research proposal) Birthplace: Brazil
Mauro obtained his PhD at the University of London and has worked in Brazil since 1997. He is a Professor of Immunology at the Department of Biochemistry and Immunology and Head of the Center for Advanced and Innovative Therapies at Universidade Federal de Minas Gerais (UFMG), Brazil. He is a full member of the Brazilian Academy of Science, of the National Order of Scientific Merit and of The World Academy of Sciences (TWAS).He is Past-president of the Brazilian Society of Pharmacology (SBFTE) and of the Brazilian Society of Inflammation (SBIN). Currently he is vice-president of International Association of Inflammation Societies (IAIS) and chair of the Immunotherapy Committee of the International Union of Immunological Societies (IUIS). He is member of the Medicines advisory board (CATEME) for Anvisa. Mauro works in the field of inflammation with particular emphasis on the role of role of inflammation for disease and death following infection. He coordinates the National Institute of Science and Technology in Dengue and host-microbial interactions (INCT Dengue). He is recognised as a world leader in Dengue research. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Health, defined by the World Health Organization (WHO) as a state of complete physical, mental and social well-being, and not just the absence of illness or infirmity, is a basic dimension of life, whether for individuals or for societies and nations. A complex set of policies and actions have been structured by nations and their governments, at different levels, to ensure the adequate pr…
The development of T cells engineered to express a chimeric antigen receptor (called CART cells) has revolutionized the treatment of some types of hematological tumors. There are also important challenges to the broader use of this technology, including the time and high cost of manufacturing, the potential adverse effects associated with viral vectors and the lack of approved products ag…
| 1 / 1 | Ongoing grants |
| 1 / 1 | Completed scholarships in Brazil |
| 2 / 2 | All research grants and scholarships |
| Associated processes | |